James Deal - Amsurg Corp Independent Director
Director
Mr. James A. Deal is Independent Director of the Company. He was director of AMSURG since 1992, serves as President Chief Executive Officer and Director of Hospice Compassus, a private equity backed hospice provider. From January through July 2006, Mr. Deal served as Chairman of the Board of INSPIRIS and from November 2001 through December 2005 as Chairman and Chief Executive Officer of INSPIRIS. From September 1998 to June 2001, Mr. Deal served as President, Chief Executive Officer and a Director of Center for Diagnostic Imaging, Inc., a national network of outpatient diagnostic imaging centers since 2016.
| Age | 65 |
| Tenure | 8 years |
| Phone | 615 665-1283 |
| Web | www.amsurg.com |
Amsurg Corp Management Efficiency
The company has return on total asset (ROA) of 3.48 % which means that it generated a profit of $3.48 on every $100 spent on assets. This is normal as compared to the sector avarege. Amsurg Corp's management efficiency ratios could be used to measure how well Amsurg Corp manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 2.38 B in liabilities with Debt to Equity (D/E) ratio of 0.83, which is about average as compared to similar companies. Amsurg Corp has a current ratio of 1.62, which is within standard range for the sector. Debt can assist Amsurg Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Amsurg Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amsurg Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amsurg to invest in growth at high rates of return. When we think about Amsurg Corp's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Takao Seki | NH Foods Ltd | N/A | |
| Mark Zupan | Constellation Brands Class | 54 | |
| Leslie Keating | SunOpta | 57 | |
| Kohei Akiyama | NH Foods Ltd | N/A | |
| Charles Herington | Molson Coors Brewing | 60 | |
| Evan Davies | Diageo PLC ADR | 67 | |
| Roger Eaton | Molson Coors Brewing | 59 | |
| Fumio Maeda | NH Foods Ltd | 58 | |
| Antonio Maciel | Marfrig Global Foods | N/A | |
| Marcia Santos | Marfrig Global Foods | N/A | |
| Nobuyuki Tazawa | NH Foods Ltd | N/A | |
| Masashi Kataoka | NH Foods Ltd | N/A | |
| Margaret Atkins | SunOpta | 61 | |
| Shan Atkins | SunOpta | 59 | |
| Katsumi Inoue | NH Foods Ltd | 62 | |
| Shuji Ohkoso | NH Foods Ltd | N/A | |
| Siobhan Moriarty | Diageo PLC ADR | 54 | |
| Sadakazu Ogawa | NH Foods Ltd | N/A | |
| Jennifer Daniels | Constellation Brands Class | 57 | |
| Herculano Alves | Marfrig Global Foods | 62 | |
| Valerie ChapoulaudFloquet | Diageo PLC ADR | 58 | |
Management Performance
| Return On Equity | 0.001 | |||
| Return On Asset | 3.48 |
Amsurg Corp Leadership Team
Elected by the shareholders, the Amsurg Corp's board of directors comprises two types of representatives: Amsurg Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amsurg. The board's role is to monitor Amsurg Corp's management team and ensure that shareholders' interests are well served. Amsurg Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amsurg Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Craig Wilson, Senior Vice President General Counsel, Secretary | ||
| Ronald Williams, Independent Director | ||
| John Popp, Independent Director | ||
| Thomas Cigarran, Co-Founder, Director and Member of Nominating and Corporate Governance Committee | ||
| Claire Gulmi, CFO, Executive VP, Secretary and Director | ||
| Kevin Lavender, Independent Director | ||
| Carol Burt, Director | ||
| Henry Herr, Independent Director | ||
| Joey Jacobs, Independent Director | ||
| Robert Coward, President - Physician Services and Chief Development Officer | ||
| Leonard Riggs, Independent Director | ||
| Phillip Clendenin, President of Ambulatory Services | ||
| Cynthia Miller, Independent Director | ||
| James Deal, Independent Director | ||
| James Shelton, Independent Director | ||
| Kevin Eastridge, Chief Accounting Officer and Sr. VP of Fin. | ||
| Michael Smith, Independent Director | ||
| Christopher Holden, CEO and President and Director | ||
| Steven Geringer, Independent Chairman of the Board | ||
| John Gawaluck, Director | ||
| William Sanger, Executive Chairman of the Board | ||
| Randel Owen, Executive Vice President and President — Ambulatory Services Group | ||
| Bob Kneeley, VP of Investor Relations |
Amsurg Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amsurg Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.001 | |||
| Return On Asset | 3.48 | |||
| Profit Margin | 7.36 % | |||
| Operating Margin | 20.55 % | |||
| Current Valuation | 5.75 B | |||
| Shares Outstanding | 48.06 M | |||
| Shares Owned By Insiders | 2.19 % | |||
| Shares Owned By Institutions | 97.81 % | |||
| Number Of Shares Shorted | 12.55 M | |||
| Price To Earning | 20.06 X |
Pair Trading with Amsurg Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amsurg Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amsurg Corp will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Goodyear Tire could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Goodyear Tire when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Goodyear Tire - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Goodyear Tire Rubber to buy it.
The correlation of Goodyear Tire is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Goodyear Tire moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Goodyear Tire Rubber moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Goodyear Tire can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Amsurg Stock
If you are still planning to invest in Amsurg Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amsurg Corp's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |